CapsoVision vs Nano-X Imaging
CapsoVision reported revenue of $14 million in fiscal 2025, about the same as Nano-X Imaging's $13 million in fiscal 2025. CapsoVision's revenue grew 15.3% in its latest year, and Nano-X Imaging's grew 15.4%. CapsoVision had an operating margin of -188.2%, against -600.8% at Nano-X Imaging. Free cash flow was −$23 million at CapsoVision and −$45 million at Nano-X Imaging.
Side by side
| CapsoVision | Nano-X Imaging | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $14M | $13M |
| Revenue growth | 15.3% | 15.4% |
| Revenue growth a year, last 5 years | — | — |
| Gross margin | 52.9% | −98.2% |
| Operating margin | −188.2% | −600.8% |
| Net margin | −186.8% | −576.1% |
| Free cash flow | −$23M | −$45M |
| Free cash flow margin | −169.3% | −345.6% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 1,115.6% | 10.4% |
| Last close | $6.31 | $0.23 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $16.0 million, sold $0 | — |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CapsoVisionNano-X Imaging
Operating margin
Percent of revenue
CapsoVisionNano-X Imaging
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CapsoVisionNano-X Imaging
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CapsoVision and Nano-X Imaging pages.